Skip to content

A clinical study on the feasibility and safety of abdominal endoscopic single-port surgery system to assist gynecological day surgery

A clinical study on the feasibility and safety of abdominal endoscopic single-port surgery system to assist gynecological day surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097789
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological benign disease

Interventions

Domestic laparoscopic single-port surgical system group:None

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18 to 75 years old, with a body mass index (BMI) of no more than 32 kg/m^2; 2. Conscious, no history of mental illness, accompanied by an adult during the perioperative period; 3. Educate the subjects, who are willing to undergo day surgery, understand and accept the surgical method and anesthesia method; 4. Subjects and families understood perioperative care and were willing and able to complete post-discharge care; 5. Elective surgery, no serious complications affecting the operation and prognosis, aCCI age adjusted comorbidity index 0 points; 6. According to the adhesion risk scoring system of European Anti-Adhesions in Gynaecology Expert Panel (ANGEL), the adhesion risk was divided into three levels: high, medium and low. Subjects with low risk (0 to 12 points) and abdominal wall scarring and pelvic cavity B-ultrasonography do not indicate obvious pelvic cavity adhesion wiil be included.

Exclusion criteria

Exclusion criteria: 1. Moderate and high-risk patients were excluded based on ANGEL adhesion risk scoring system; 2. Subjects with hemorrhagic rupture of ectopic pregnancy and unstable vital signs; 3. Genital tract infection or in the acute phase of systemic infection; 4. Subjects on long-term anticoagulant therapy or with coagulation dysfunction; 5. Subjects have severe heart and lung disease, liver and kidney dysfunction, and cannot tolerate anesthesia; 6. A history of abdominal or diaphragmatic hernia, abnormal umbilical cord development, or umbilical cord surgery; 7. Not willing to undergo endoscopic surgery; 8. Participated in other drug and device clinical trials within 3 months before surgery.

Design outcomes

Primary

MeasureTime frame
day surgery success rate;

Secondary

MeasureTime frame
time of operation;blood loss evaluation;surgeon satisfaction evaluation;time of first postoperative anal exhaust;first spontaneous urination time;pain score;hospital stays;postoperative rehabilitation evaluation;abdominal incision healing;scar satisfaction;discharge assessment;postoperative complication;quality and safety evaluation of day surgery;safety evaluation;

Countries

China

Contacts

Public ContactDuan Ping

The Second Affiliated Hospital of Wenzhou Medical University

dppddpp@126.com+86 135 8743 0406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026